ATE412895T1 - Verfahren zur untersuchung der wirkung eines angiogenese-hemmers unter vermittlung durch hemmung der integrin-expression - Google Patents
Verfahren zur untersuchung der wirkung eines angiogenese-hemmers unter vermittlung durch hemmung der integrin-expressionInfo
- Publication number
- ATE412895T1 ATE412895T1 AT06013455T AT06013455T ATE412895T1 AT E412895 T1 ATE412895 T1 AT E412895T1 AT 06013455 T AT06013455 T AT 06013455T AT 06013455 T AT06013455 T AT 06013455T AT E412895 T1 ATE412895 T1 AT E412895T1
- Authority
- AT
- Austria
- Prior art keywords
- integrin expression
- studying
- inhibition
- effect
- angiogenesis inhibitor
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70546—Integrin superfamily
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001044646 | 2001-02-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE412895T1 true ATE412895T1 (de) | 2008-11-15 |
Family
ID=18906601
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02700679T ATE350660T1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression |
AT06013455T ATE412895T1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur untersuchung der wirkung eines angiogenese-hemmers unter vermittlung durch hemmung der integrin-expression |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02700679T ATE350660T1 (de) | 2001-02-21 | 2002-02-21 | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression |
Country Status (12)
Country | Link |
---|---|
US (1) | US7122318B2 (de) |
EP (2) | EP1362601B8 (de) |
JP (1) | JP4255285B2 (de) |
KR (1) | KR20030080013A (de) |
CN (2) | CN101025419A (de) |
AT (2) | ATE350660T1 (de) |
AU (1) | AU2002233677B2 (de) |
CA (1) | CA2438427C (de) |
DE (2) | DE60229676D1 (de) |
ES (2) | ES2317368T3 (de) |
HK (2) | HK1059038A1 (de) |
WO (1) | WO2002066073A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE350660T1 (de) | 2001-02-21 | 2007-01-15 | Eisai Co Ltd | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression |
TW589181B (en) * | 2001-09-05 | 2004-06-01 | Eisai Co Ltd | Lymphocytic activation inhibitor and remedial agent for autoimmune disease |
WO2005090297A1 (en) * | 2004-03-19 | 2005-09-29 | Biotie Therapies Corporation | Sulphonamide derivatives |
WO2006090921A1 (ja) * | 2005-02-28 | 2006-08-31 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物のリンパ球活性化抑制作用 |
EP3088400A1 (de) | 2005-06-22 | 2016-11-02 | Plexxikon Inc. | Pyrrolo[2,3-b]pyridin-derivate als proteinkinasehemmer |
FI20055498A0 (fi) * | 2005-09-16 | 2005-09-16 | Biotie Therapies Corp | Sulfonamidijohdannaisia |
WO2007086605A1 (ja) * | 2006-01-27 | 2007-08-02 | Eisai R & D Management Co., Ltd. | スルホンアミド化合物の効果を予測する方法 |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
AU2019373242B2 (en) | 2018-10-30 | 2023-07-13 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
AU2019373245C1 (en) | 2018-10-30 | 2022-10-27 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4β7 integrin |
JP7214882B2 (ja) | 2018-10-30 | 2023-01-30 | ギリアード サイエンシーズ, インコーポレイテッド | アルファ4ベータ7インテグリン阻害剤としてのイミダゾピリジン誘導体 |
CN112969687A (zh) | 2018-10-30 | 2021-06-15 | 吉利德科学公司 | 作为α4β7整合素抑制剂的喹啉衍生物 |
KR20220047323A (ko) | 2019-08-14 | 2022-04-15 | 길리애드 사이언시즈, 인코포레이티드 | 알파 4 베타 7 인테그린의 저해용 화합물 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3545461B2 (ja) * | 1993-09-10 | 2004-07-21 | エーザイ株式会社 | 二環式ヘテロ環含有スルホンアミド誘導体 |
ATE255106T1 (de) * | 1993-09-10 | 2003-12-15 | Eisai Co Ltd | Bicyclische, heterocyclische sulfonamide und sulfonsäureester |
ES2160949T3 (es) * | 1996-03-29 | 2001-11-16 | Searle & Co | Derivados de fenilen-sulfonamida sustituidos en meta. |
CN1226172A (zh) * | 1996-05-31 | 1999-08-18 | 斯克里普斯研究学院 | 用于抑制血管发生的方法和组合物 |
AU724216B2 (en) * | 1997-04-07 | 2000-09-14 | Merck & Co., Inc. | A method of treating cancer |
US6096707A (en) * | 1997-07-11 | 2000-08-01 | Biotie Therapies Ltd. | Integrin binding peptide and use thereof |
US6291503B1 (en) * | 1999-01-15 | 2001-09-18 | Bayer Aktiengesellschaft | β-phenylalanine derivatives as integrin antagonists |
JP2000247949A (ja) * | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
HUP0300544A3 (en) | 2000-02-03 | 2005-03-29 | Eisai Co Ltd | Pharmaceutical compositions containing integrin expression inhibitors |
ATE350660T1 (de) | 2001-02-21 | 2007-01-15 | Eisai Co Ltd | Verfahren zur untersuchung der wirkung eines angionegesis-hemmers unter vermittlung durch hemmung der integrin-expression |
-
2002
- 2002-02-21 AT AT02700679T patent/ATE350660T1/de active
- 2002-02-21 DE DE60229676T patent/DE60229676D1/de not_active Expired - Lifetime
- 2002-02-21 US US10/468,615 patent/US7122318B2/en not_active Expired - Fee Related
- 2002-02-21 JP JP2002565631A patent/JP4255285B2/ja not_active Expired - Fee Related
- 2002-02-21 ES ES06013455T patent/ES2317368T3/es not_active Expired - Lifetime
- 2002-02-21 AU AU2002233677A patent/AU2002233677B2/en not_active Ceased
- 2002-02-21 CN CNA2007100878177A patent/CN101025419A/zh active Pending
- 2002-02-21 KR KR10-2003-7010944A patent/KR20030080013A/ko active Search and Examination
- 2002-02-21 EP EP02700679A patent/EP1362601B8/de not_active Expired - Lifetime
- 2002-02-21 EP EP06013455A patent/EP1742052B1/de not_active Expired - Lifetime
- 2002-02-21 WO PCT/JP2002/001562 patent/WO2002066073A1/ja active IP Right Grant
- 2002-02-21 CN CNB028086376A patent/CN100384482C/zh not_active Expired - Fee Related
- 2002-02-21 DE DE60217300T patent/DE60217300T2/de not_active Expired - Lifetime
- 2002-02-21 CA CA2438427A patent/CA2438427C/en not_active Expired - Fee Related
- 2002-02-21 ES ES02700679T patent/ES2280502T3/es not_active Expired - Lifetime
- 2002-02-21 AT AT06013455T patent/ATE412895T1/de active
-
2004
- 2004-03-16 HK HK04101904A patent/HK1059038A1/xx not_active IP Right Cessation
-
2007
- 2007-06-26 HK HK07106835A patent/HK1099363A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60217300D1 (de) | 2007-02-15 |
EP1362601B8 (de) | 2007-02-28 |
CN100384482C (zh) | 2008-04-30 |
EP1362601B1 (de) | 2007-01-03 |
CA2438427A1 (en) | 2002-08-29 |
US20040132783A1 (en) | 2004-07-08 |
ES2280502T3 (es) | 2007-09-16 |
JP4255285B2 (ja) | 2009-04-15 |
HK1099363A1 (en) | 2007-08-10 |
JPWO2002066073A1 (ja) | 2004-06-17 |
HK1059038A1 (en) | 2004-06-18 |
CN101025419A (zh) | 2007-08-29 |
DE60229676D1 (de) | 2008-12-11 |
DE60217300T2 (de) | 2007-10-04 |
CA2438427C (en) | 2011-04-12 |
EP1362601A1 (de) | 2003-11-19 |
ES2317368T3 (es) | 2009-04-16 |
WO2002066073A1 (fr) | 2002-08-29 |
EP1742052B1 (de) | 2008-10-29 |
US7122318B2 (en) | 2006-10-17 |
KR20030080013A (ko) | 2003-10-10 |
EP1362601A4 (de) | 2005-07-06 |
AU2002233677B2 (en) | 2005-01-06 |
EP1742052A1 (de) | 2007-01-10 |
ATE350660T1 (de) | 2007-01-15 |
CN1620313A (zh) | 2005-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE412895T1 (de) | Verfahren zur untersuchung der wirkung eines angiogenese-hemmers unter vermittlung durch hemmung der integrin-expression | |
DE60124736D1 (de) | Vorrichtung zur messung des abschnittsweisen volumens und der elektrischen parallelleitfähigkeit einer herzkammer oder eines blutgefässes | |
ATE404890T1 (de) | Verfahren und vorrichtung zur schnellen tomographischen messung der elektrischen leitfähigkeitsverteilung in einer probe | |
ATE511549T1 (de) | Kit zur messung der thrombinerzeugung in einer blut- oder plasmaprobe eines patienten | |
BR0315287A (pt) | Método para determinar a exatidão de um sensor de pressão em um cassete cirúrgico | |
DE10343896A1 (de) | Testgerät zur Untersuchung von Körperflüssigkeiten | |
DE60010224D1 (de) | Vorrichtung, computersystem und computerprogramm zur bestimmung eines kardiovasculären parameters | |
EP1707955A3 (de) | Verfahren zur Bestimmung der Geschwindigkeit einer Spannungswelle in einem Material und Homogenität der Eigenschaften im Material | |
AR041513A1 (es) | Sensado de presion en consola quirurgica | |
DE60315151D1 (de) | Diagnostischer test zur bestimmung der konzentration einer transienten proteolytischen aktivität in zusammengesetzten biologischen medien | |
DE50213952D1 (de) | Sensoranordnung | |
CN101512011A (zh) | 在生物介质中测定酶活性的方法 | |
Lawson et al. | Tear strength of five elastomeric impression materials at two setting times and two tearing rates | |
ATE313788T1 (de) | Feuchtigkeitsfühler mit kapazitivem feuchte- messelement und verfahren zur erfassung der luftfeuchtigkeit | |
ATE335434T1 (de) | Vorrichtung und verfahren zur messung der vaskulären impedanz | |
ATE530906T1 (de) | Verfahren zur unterscheidung zwischen einen gemeinsamen analyten enthaltenden blut- und kontrollösungen | |
DE60112949D1 (de) | Verfahren zum nachweis eines lipoprotein-akutphaseprotein-komplexes | |
DE502006006663D1 (de) | Verfahren und vorrichtung zur messung der einspritzmenge und der einspritzrate eines einspritzventils für flüssigkeiten | |
ATE469347T1 (de) | Verfahren und vorrichtung zum testen eines objekts mit ultraschall | |
DE60203524D1 (de) | Verfahren zur messung des arteriolendrucks | |
DE502004011337D1 (de) | Verfahren zur messung eines drucks | |
DE602008006604D1 (de) | Verfahren zur verarbeitung von spaltkammermesssignalen | |
ATE295797T1 (de) | Verfahren zum erzeugen eines einen lagerschaden an einem achslager angebenden alarmsignals | |
DE50009357D1 (de) | Verfahren zur bestimmung der belastbarkeit eines menschen | |
ATE535776T1 (de) | Verfahren zur erkennung von dentalen oberflächenstrukturen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1742052 Country of ref document: EP |